Airway narrowing in healthy humans inhaling methacholine without deep inspirations demonstrated by HRCT

Robert Howard Brown, Pierre Croisille, Beatrice Mudge, Fiona B. Diemer, Solbert Permutt, Alkis Togias

Research output: Contribution to journalArticle

Abstract

Normal subjects prevented from taking a deep breath show changes in airflow similar to those of asthmatics when challenged with methacholine (MCh). To confirm airway narrowing by MCh in this setting and to determine its location, we concurrently measured changes in airway lumenal area using high resolution computed tomography (HRCT) and airflow using partial spirometry in five normal subjects challenged with increasing doses of MCh under prohibition of deep breaths. In an attempt to improve imaging accuracy, we corrected for the changes in lung volume during bronchoprovocation. At every step of the provocation, scanning was performed at approximately the same lung volume. On the HRCT images, airway area decreased in response to the increasing doses of MCh to 91 (+) 2%, 88 (+) 2%, and 80 (+) 2% of baseline at the doses of MCh 0.25, 0.75, and 2.5 mg/ml, respectively (p <0.001). Airway narrowing showed no predilection for particular airway sizes and occurred in a heterogeneous pattern. The changes in the mean airway lumenal area as measured by HRCT and the mean partial spirometric outcomes were highly correlated: FEV1p (r2 = 0.46, p = 0.001), FVCp (r2 = 0.20, p = 0.05), FEV1/FVCp (r2 = 0.55, p = 0.002), MMEFp (r2 = 0.31, p = 0.01), and τp (r2 = 0.51, p = 0.0004). We conclude that in normal subjects who are prevented from taking a deep breath, the spirometric changes occurring with aerosol MCh challenge are associated with conducting airway narrowing.

Original languageEnglish (US)
Pages (from-to)1256-1263
Number of pages8
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume161
Issue number4 I
StatePublished - 2000

Fingerprint

Methacholine Chloride
Inhalation
Tomography
Lung
Spirometry
Aerosols

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Airway narrowing in healthy humans inhaling methacholine without deep inspirations demonstrated by HRCT. / Brown, Robert Howard; Croisille, Pierre; Mudge, Beatrice; Diemer, Fiona B.; Permutt, Solbert; Togias, Alkis.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 161, No. 4 I, 2000, p. 1256-1263.

Research output: Contribution to journalArticle

Brown, Robert Howard ; Croisille, Pierre ; Mudge, Beatrice ; Diemer, Fiona B. ; Permutt, Solbert ; Togias, Alkis. / Airway narrowing in healthy humans inhaling methacholine without deep inspirations demonstrated by HRCT. In: American Journal of Respiratory and Critical Care Medicine. 2000 ; Vol. 161, No. 4 I. pp. 1256-1263.
@article{2f947277abd040df957485c88dec29f2,
title = "Airway narrowing in healthy humans inhaling methacholine without deep inspirations demonstrated by HRCT",
abstract = "Normal subjects prevented from taking a deep breath show changes in airflow similar to those of asthmatics when challenged with methacholine (MCh). To confirm airway narrowing by MCh in this setting and to determine its location, we concurrently measured changes in airway lumenal area using high resolution computed tomography (HRCT) and airflow using partial spirometry in five normal subjects challenged with increasing doses of MCh under prohibition of deep breaths. In an attempt to improve imaging accuracy, we corrected for the changes in lung volume during bronchoprovocation. At every step of the provocation, scanning was performed at approximately the same lung volume. On the HRCT images, airway area decreased in response to the increasing doses of MCh to 91 (+) 2{\%}, 88 (+) 2{\%}, and 80 (+) 2{\%} of baseline at the doses of MCh 0.25, 0.75, and 2.5 mg/ml, respectively (p <0.001). Airway narrowing showed no predilection for particular airway sizes and occurred in a heterogeneous pattern. The changes in the mean airway lumenal area as measured by HRCT and the mean partial spirometric outcomes were highly correlated: FEV1p (r2 = 0.46, p = 0.001), FVCp (r2 = 0.20, p = 0.05), FEV1/FVCp (r2 = 0.55, p = 0.002), MMEFp (r2 = 0.31, p = 0.01), and τp (r2 = 0.51, p = 0.0004). We conclude that in normal subjects who are prevented from taking a deep breath, the spirometric changes occurring with aerosol MCh challenge are associated with conducting airway narrowing.",
author = "Brown, {Robert Howard} and Pierre Croisille and Beatrice Mudge and Diemer, {Fiona B.} and Solbert Permutt and Alkis Togias",
year = "2000",
language = "English (US)",
volume = "161",
pages = "1256--1263",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "4 I",

}

TY - JOUR

T1 - Airway narrowing in healthy humans inhaling methacholine without deep inspirations demonstrated by HRCT

AU - Brown, Robert Howard

AU - Croisille, Pierre

AU - Mudge, Beatrice

AU - Diemer, Fiona B.

AU - Permutt, Solbert

AU - Togias, Alkis

PY - 2000

Y1 - 2000

N2 - Normal subjects prevented from taking a deep breath show changes in airflow similar to those of asthmatics when challenged with methacholine (MCh). To confirm airway narrowing by MCh in this setting and to determine its location, we concurrently measured changes in airway lumenal area using high resolution computed tomography (HRCT) and airflow using partial spirometry in five normal subjects challenged with increasing doses of MCh under prohibition of deep breaths. In an attempt to improve imaging accuracy, we corrected for the changes in lung volume during bronchoprovocation. At every step of the provocation, scanning was performed at approximately the same lung volume. On the HRCT images, airway area decreased in response to the increasing doses of MCh to 91 (+) 2%, 88 (+) 2%, and 80 (+) 2% of baseline at the doses of MCh 0.25, 0.75, and 2.5 mg/ml, respectively (p <0.001). Airway narrowing showed no predilection for particular airway sizes and occurred in a heterogeneous pattern. The changes in the mean airway lumenal area as measured by HRCT and the mean partial spirometric outcomes were highly correlated: FEV1p (r2 = 0.46, p = 0.001), FVCp (r2 = 0.20, p = 0.05), FEV1/FVCp (r2 = 0.55, p = 0.002), MMEFp (r2 = 0.31, p = 0.01), and τp (r2 = 0.51, p = 0.0004). We conclude that in normal subjects who are prevented from taking a deep breath, the spirometric changes occurring with aerosol MCh challenge are associated with conducting airway narrowing.

AB - Normal subjects prevented from taking a deep breath show changes in airflow similar to those of asthmatics when challenged with methacholine (MCh). To confirm airway narrowing by MCh in this setting and to determine its location, we concurrently measured changes in airway lumenal area using high resolution computed tomography (HRCT) and airflow using partial spirometry in five normal subjects challenged with increasing doses of MCh under prohibition of deep breaths. In an attempt to improve imaging accuracy, we corrected for the changes in lung volume during bronchoprovocation. At every step of the provocation, scanning was performed at approximately the same lung volume. On the HRCT images, airway area decreased in response to the increasing doses of MCh to 91 (+) 2%, 88 (+) 2%, and 80 (+) 2% of baseline at the doses of MCh 0.25, 0.75, and 2.5 mg/ml, respectively (p <0.001). Airway narrowing showed no predilection for particular airway sizes and occurred in a heterogeneous pattern. The changes in the mean airway lumenal area as measured by HRCT and the mean partial spirometric outcomes were highly correlated: FEV1p (r2 = 0.46, p = 0.001), FVCp (r2 = 0.20, p = 0.05), FEV1/FVCp (r2 = 0.55, p = 0.002), MMEFp (r2 = 0.31, p = 0.01), and τp (r2 = 0.51, p = 0.0004). We conclude that in normal subjects who are prevented from taking a deep breath, the spirometric changes occurring with aerosol MCh challenge are associated with conducting airway narrowing.

UR - http://www.scopus.com/inward/record.url?scp=0034057271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034057271&partnerID=8YFLogxK

M3 - Article

VL - 161

SP - 1256

EP - 1263

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 4 I

ER -